WP1
Technology & algorithm development and maintenance
About COVID-RED
COVID-RED is a project that is part of the EU Innovative Medicines Initivative and will evaluate the use and performance of a CE-marked device (wearable), which uses sensors to measure breathing rate, pulse rate, skin temperature, and heart rate variability for the purpose of early detection and monitoring of COVID-19 in general and high-risk populations. At the same time, a mobile application will be used to track participant-reported symptoms.
| READ MORE >>
NEWS
Press release in The Guardian based on the scientific publication in BMJ Open
Jul
22
2022
Read more
Poster presentatie bij de AGOG Annual Clinical & Scientific Meeting
Jul
01
2022
Read more
Poster presentatie bij de AGOG Annual Clinical & Scientific Meeting
Jul
01
2022
Brianna Goodale, Work Package 1 lead at COVID-RED and Director of Medical Affairs at Ava Women, has presented a poster at the annual meeting of The American College of Obstetricians and Gynecologists (ACOG). The poster, titled Menstrual cycle influence on COVID-19 detection using machine learning and a wearable medical device, can be accessed here.
COVID-RED
Your support in the fight against COVID-19
The COVID-RED consortium
The COVID-RED consortium brings together nine organisations from four countries with the aim to deliver a large body of information on COVID-19 monitoring that can be used to develop additional diagnostics and therapeutics in addition to validating remote vital signs and self-reported symptoms monitoring systems.
The COVID-RED project has received funding from the Innovative Medicines Initiative 2 Joint Undertaking under grant agreement No 101005177. This Joint Undertaking receives support from the European Union's Horizon 2020 research and innovation programme and EFPIA.